Silver Book Fact

The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.

Rosen A, Cutler D, Norton D, Hu H. The Value of Coronary Heart Disease Care for the Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.26.1.111

Reference

Title
The Value of Coronary Heart Disease Care for the Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen A, Cutler D, Norton D, Hu H
Volume & Issue
Volume 26, Issue 1
Pages
111-123
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Echocardiography and nuclear imaging are used for provocative “stress” testing of the heart. When combined with other forms of stress, both can identify the presence of coronary artery-obstructing lesions that…  
  • Death Rates for Coronary Heart Disease, 1950-1998  
  • Antihypertensive treatment has generated a benefit-to-cost ratio of at least 6:1 (6:1 in women and 10:1 in men).  
  • Pioglitazone associated with relative risk reduction in recurrent stroke
    The PROactive trial to manage glucose in diabetics with a history of cardiovascular disease, stroke, or other vascular risk factors found that treatment with pioglitazone was associated with a 47% relative…  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…